NEW YORK — CareDx said on Wednesday that it has priced a planned $125 million public stock offering at $32 per share.
The Brisbane, California-based molecular diagnostics firm said it will offer 3,906,250 shares of its common stock through the transaction. It said it has also granted the underwriters of the offering a 30-day option to buy an additional 585,937 shares at the offering price, which would raise another $18.7 million.
The offering is expected to close on or around June 15. CareDx's stock closed at $33.51 on the Nasdaq Wednesday.